Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Deficit (Tables)

v3.21.2
Shareholders' Deficit (Tables)
 9 Months Ended
Sep. 30, 2021
Stockholders' Equity Note [Abstract]  
Schedule of activity related to non-vested shares
    Number of
Non-Vested
Shares		     Weighted
Average
Grant Date
Fair Value		  
Non-vested, December 31, 2020     23,826,926     $ 0.16  
Granted     6,194,767       0.06  
Forfeited     (700,000 )     (0.07 )
Shares vested     (15,051,573 )     (0.14 )
Non-vested, September 30, 2021     14,270,120     $ 0.14  

Schedule of stock option activities
    Number of Options     Weighted Average
Exercise Price		     Weighted
Average
Remaining
Contractual
Term (Years)		     Aggregate Intrinsic
Value		  
Balance Outstanding, December 31, 2020     8,445,698     $ 0.40       5.10     $ 48,000  
Granted    
-
      
-
      
-
      
-
  
Forfeited    
-
      
-
      
-
      
-
  
Balance Outstanding, September 30, 2021     8,445,698     $ 0.40       4.33     $ 2,160  
Exercisable, September 30, 2021     8,445,698     $ 0.40       4.33     $ 2,160  

 
Schedule of warrant activities
    Number of Warrants     Weighted Average
Exercise Price		     Weighted
Average
Remaining
Contractual
Term (Years)		     Aggregate
Intrinsic Value		  
Balance Outstanding December 31, 2020     2,050,000     $ 0.05       3.66     $ 137,000  
Exercised     (1,050,000 )     0.01      
-
      
-
  
Cancelled    
-
      
-
      
-
      
-
  
Balance Outstanding September 30, 2021     1,000,000     $ 0.09       2.80     $ -  
Exercisable, September 30, 2021     1,000,000     $ 0.09       2.80     $ -